Life-threatening retroperitoneal bleeding due to warfarin-drug interactions

Pharmacoepidemiology and Drug Safety

Volumn 18, Issue 5, 2009, Pages 420-422

  Chan, Thomas Y K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Drug interactions; Methyl salicylate; Retroperitoneal bleeding; Warfarin

Indexed keywords

AMIODARONE; ANALGESIC AGENT; BUDESONIDE; CEFEPIME; CIPROFLOXACIN; DEXTROPROPOXYPHENE; ENOXAPARIN; ESOMEPRAZOLE; FAMOTIDINE; FRESH FROZEN PLASMA; FUROSEMIDE; HALOPERIDOL; HEMOGLOBIN; HEPARIN; HYDROCORTISONE; IPRATROPIUM BROMIDE; LACTULOSE; NADROPARIN; PARACETAMOL; PHYTOMENADIONE; PIPERACILLIN PLUS TAZOBACTAM; POTASSIUM CHLORIDE; PREDNISOLONE; SALBUTAMOL; SALICYLIC ACID METHYL ESTER; WARFARIN; ANTICOAGULANT AGENT; SALICYLIC ACID DERIVATIVE;

ABDOMINAL MASS; ABDOMINAL PAIN; ADULT; ANTICOAGULATION; ARTICLE; CARDIOMEGALY; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; COR PULMONALE; DEEP VEIN THROMBOSIS; DRUG POTENTIATION; ERYTHROCYTE CONCENTRATE; HEART ATRIUM FIBRILLATION; HEART RIGHT VENTRICLE HYPERTROPHY; HEMATOMA; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERNATIONAL NORMALIZED RATIO; LEG PAIN; LEG SWELLING; LOADING DRUG DOSE; LUNG EMBOLISM; MALE; MORNING DOSAGE; PAIN; PARESTHESIA; PARTIAL THROMBOPLASTIN TIME; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETROPERITONEAL HEMORRHAGE; SINUS TACHYCARDIA; THORAX RADIOGRAPHY; VENA CAVA FILTER; BLEEDING; CHEMICALLY INDUCED DISORDER; DRUG INTERACTION; MIDDLE AGED; RETROPERITONEUM;

ANTICOAGULANTS; DRUG INTERACTIONS; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; RETROPERITONEAL SPACE; SALICYLATES; WARFARIN;

EID: 67649402276     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1729     Document Type: Article

References (15)

1. Chan TYK. Drug interactions as a cause of overanticoagulation and bleedings in Chinese patients receiving warfarin. Int J Clin Pharmacol Ther 1998; 36: 403-405.
2. Jonsson AK, Spigset O, Jacobsson I, Hagg S. Cerebral haemorrhage induced by warfarin - the influence of drug-drug interactions. Pharmacoepidemiol Drug Saf 2007; 16: 309-315.
3. Chan TYK. Recognizing increased sensitivity to warfarin in liver dysfunction secondary to congestive heart failure. Pharmacoepidemiol Drug Saf [Letter] 1996; 5: 53-54.
4. Morra P, Bartle WR, Walker SE, Lee SN, Bowles SK, Reeves RA. Serum concentrations of salicylic acid following topically applied salicylate derivatives. Ann Pharmacother 1996; 30: 935-940.
5. Roncaglioni MC, Ulrich MM, Muller AD, Soute BA, de Boer-van den Berg MA, Vermeer C. The vitamin K-antagonism of salicylate and warfarin. Thromb Res 1986; 42: 727-736.
6. Chan TYK. Potential dangers from topical preparations containing methyl salicylate. Hum Exp Toxicol 1996; 15: 747-750.
7. Yip AS, Chow WH, Tai YT, Cheung KL. Adverse effect of topical methylsalicylate ointment on warfarin anticoagulation: an unrecognized potential hazard. Postgrad Med J 1990; 66: 367-369.
8. Leclerc-Foucras S, Bagheri H, Samii K, Montastruc JL, Lapeyre-Mestre M. French Medicine Agency, Modifications of low-molecular weight heparin use in a French university hospital after implementation of new guidelines. Drug Saf 2007; 30: 409-417.
9. Juurlink DN. Drug interactions with warfarin: what clinicians need to know. CMAJ 2007; 177: 369-371.
10. Macie C, Forbes L, Foster GA, Douketis JD. Dosing practices and risk factors for bleeding in patients receiving enoxaparin for the treatment of an acute coronary syndrome. Chest 2004; 125: 1616-1621.
11. Herman D, Locatelli I, Grabnar I, et al. The influence of co-treatment with carbamazepine, amiodarone and statins on warfarin metabolism and maintenance dose. Eur J Clin Pharmacol 2006; 62: 291-296.
12. Sanoski CA, Bauman JL. Clinical observations with the amiodarone/ warfarin interaction dosing relationships with long-term therapy. Chest 2002; 121: 19-23.
13. Yu HCM, Chan TYK, Critchley JAJH, Woo KS. Factors determining the maintenance dose of warfarin in Chinese patients. Q J M 1996; 89: 127-135.
14. Mahe I, Bertrand N, Drouet L, et al. Paracetamol: a haemorrhagic risk factor in patients on warfarin. Br J Clin Pharmacol 2005; 59: 371-374.
15. Parra D, Beckey NP, Stevens GR. The effect of acetaminophen on the international normalized ratio in patients stabilized on warfarin therapy. Pharmacotherapy 2007; 27: 675-683.